American Century Companies’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204M Buy
414,395
+41,929
+11% +$22.8M 0.1% 184
2025
Q4
$216M Buy
372,466
+98,851
+36% +$55.9M 0.11% 167
2025
Q3
$133M Buy
273,615
+170,888
+166% +$79.5M 0.07% 296
2025
Q2
$41.7M Sell
102,727
-1,051
-1% -$439K 0.02% 754
2025
Q1
$51.6M Sell
103,778
-6,028
-5% -$3.26M 0.03% 594
2024
Q4
$57.1M Sell
109,806
-6,251
-5% -$3.44M 0.03% 562
2024
Q3
$71.8M Sell
116,057
-10,239
-8% -$6.06M 0.04% 453
2024
Q2
$69.8M Sell
126,296
-6,223
-5% -$3.57M 0.04% 428
2024
Q1
$77M Sell
132,519
-18,056
-12% -$10.1M 0.05% 401
2023
Q4
$79.9M Buy
150,575
+24,363
+19% +$11.8M 0.05% 360
2023
Q3
$63.9M Sell
126,212
-4,980
-4% -$2.65M 0.05% 384
2023
Q2
$68.4M Buy
131,192
+8,005
+6% +$4.32M 0.05% 355
2023
Q1
$70.9M Sell
123,187
-11,961
-9% -$6.74M 0.06% 347
2022
Q4
$74.4M Sell
135,148
-41,578
-24% -$22M 0.06% 329
2022
Q3
$89.6M Buy
176,726
+68,749
+64% +$38.5M 0.08% 278
2022
Q2
$58.7M Buy
107,977
+13,202
+14% +$7.27M 0.05% 384
2022
Q1
$56M Buy
94,775
+156
+0.2% +$89.6K 0.04% 423
2021
Q4
$63.1M Sell
94,619
-9,938
-10% -$6.2M 0.04% 422
2021
Q3
$59.7M Buy
104,557
+4,716
+5% +$2.59M 0.04% 412
2021
Q2
$50.4M Sell
99,841
-34,985
-26% -$16.5M 0.03% 463
2021
Q1
$61.5M Buy
134,826
+43,117
+47% +$20.6M 0.05% 399
2020
Q4
$42.7M Buy
91,709
+4,337
+5% +$2.03M 0.03% 430
2020
Q3
$38.6M Buy
87,372
+42,763
+96% +$17.7M 0.03% 402
2020
Q2
$16.2M Buy
44,609
+42,893
+2,500% +$14.4M 0.02% 567
2020
Q1
$487K Sell
1,716
-44,112
-96% -$13.9M ﹤0.01% 1168
2019
Q4
$14.9M Sell
45,828
-276,684
-86% -$83.9M 0.01% 590
2019
Q3
$93.9M Sell
322,512
-122,839
-28% -$35.2M 0.09% 247
2019
Q2
$131M Buy
445,351
+2,980
+0.7% +$821K 0.13% 209
2019
Q1
$121M Buy
442,371
+61,340
+16% +$15.3M 0.12% 224
2018
Q4
$85.3M Buy
+381,031
New +$89.4M 0.1% 258
2018
Q1
Sell
-247,906
Closed -$47.1M 1333
2017
Q4
$47.1M Buy
247,906
+172,484
+229% +$33M 0.05% 387
2017
Q3
$14.3M Sell
75,422
-2,522
-3% -$457K 0.01% 595
2017
Q2
$13.6M Buy
77,944
+58,421
+299% +$9.81M 0.01% 606
2017
Q1
$3M Sell
19,523
-266,228
-93% -$40.7M ﹤0.01% 982
2016
Q4
$40.3M Sell
285,751
-197,989
-41% -$29.2M 0.04% 405
2016
Q3
$76.9M Sell
483,740
-96,353
-17% -$14.8M 0.08% 292
2016
Q2
$85.7M Buy
580,093
+12,814
+2% +$1.89M 0.1% 265
2016
Q1
$80.3M Buy
567,279
+137,750
+32% +$18.5M 0.09% 288
2015
Q4
$60.9M Buy
+429,529
New +$57.3M 0.07% 334
2014
Q2
Sell
-2,545
Closed -$306K 1515
2014
Q1
$306K Sell
2,545
-222
-8% -$26.4K ﹤0.01% 1399
2013
Q4
$308K Buy
2,767
+28
+1% +$2.78K ﹤0.01% 1389
2013
Q3
$252K Sell
2,739
-40,329
-94% -$3.65M ﹤0.01% 1420
2013
Q2
$3.65M Buy
+43,068
New +$3.59M ﹤0.01% 939

Other funds holding TMO

American Century Companies's TMO Position: Q1 2026 in Review

American Century Companies increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, buying an estimated $22.8M and bringing the position to 414,395 shares worth $204M. The position accounts for 0.1% of the portfolio, ranked #184.

American Century Companies first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. The position peaked at $216M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • American Century Companies held 414,395 shares of Thermo Fisher Scientific worth $204M as of Q1 2026.
  • American Century Companies bought 41,929 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.8M.
  • Thermo Fisher Scientific made up 0.1% of American Century Companies's portfolio in Q1 2026, its #184 holding.
  • American Century Companies first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
  • American Century Companies's Thermo Fisher Scientific position peaked at $216M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.